Volume 7 Supplement 1

12th Joint Meeting of the Signal Transduction Society (STS). Signal Transduction: Receptors, Mediators and Genes

Open Access

Drosophila GoLoco-protein Pins as a target of Gαo-mediated G protein coupled receptor signaling

  • DS Kopein1,
  • K Diederichs1 and
  • VL Katanaev1
Cell Communication and Signaling20097(Suppl 1):A104

DOI: 10.1186/1478-811X-7-S1-A104

Published: 26 February 2009

Heterotrimeric G-proteins are molecular switches that regulate numerous aspects of cellular physiology by transducing the signals from G protein-coupled receptors (GPCRs). In the basal state, the Gα-subunits of the heterotrimeric G proteins are GDP-liganded (the inactive form) and bind to the βγ-complex. GPCRs can activate guanine nucleotide exchange on the Gα-subunits to produce the active, GTP-bound state. GoLoco domains present in many proteins play important roles in multiple heterotrimeric G protein-dependent activities, physically binding the Gα-subunits of the Gαi/o class. In most cases GoLoco binds exclusively to the GDP-loaded form of the Gα-subunits. Our biochemical and genetic experiments as well as structural modeling show that the poly-GoLoco protein Pins binds to both the GDP- and GTP-forms of Drosophila Gαo. We identify the Pins GoLoco domain 1 as necessary and sufficient for the unusual interaction with Gαo-GTP. We further pinpoint the central Lysine residue present in this domain as responsible for the interaction. Molecular modeling suggests that the side chain of this Lysine points directly into the guanine nucleotide-binding pocket of Gαo, stabilizing the extra negative charges of the γ-phosphate group of GTP. Such a positively charged amino acid is unique in the Drosophila GoLoco proteome, but is conserved in several GoLoco domains of other organisms. We conclude that Pins, through its GoLoco domain 1, is a target for Gαo-mediated GPCR signaling.

Authors’ Affiliations

(1)
Department of Biology, University of Konstanz

Copyright

© Kopein et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement